United Therapeutics (UTHR) Profit After Tax (2009 - 2026)
United Therapeutics (UTHR) posted Profit After Tax of $274.9 million for Q1 2026, down 24.54% sequentially from $364.3 million in Q4 2025, and down 14.68% YoY from $322.2 million in Q1 2025.
United Therapeutics (UTHR) Profit After Tax (2009 - 2026) Analysis & Trends
United Therapeutics has reported Profit After Tax for 18 years, with the latest figure at $274.9 million in Q1 2026.
- Quarterly Profit After Tax fell 14.68% year-over-year to $274.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 6.34% YoY) and the FY2025 annual result came in at $1.3 billion, up 11.68% from the prior year.
- Profit After Tax slipped to $274.9 million in Q1 2026 per UTHR's latest filing, from $364.3 million in the prior quarter.
- Over five years, Profit After Tax peaked at $364.3 million in Q4 2025 and troughed at $116.0 million in Q2 2022.
- A 5-year average of $265.7 million and a median of $274.9 million in 2026 frame the typical range for Profit After Tax.
- The widest YoY moves for Profit After Tax: up 747.7% in 2022, down 32.79% in 2022.
- Over 5 years, Profit After Tax stood at $132.1 million in 2022, then surged by 64.35% to $217.1 million in 2023, then surged by 38.78% to $301.3 million in 2024, then advanced by 20.91% to $364.3 million in 2025, then dropped by 24.54% to $274.9 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $274.9 million, $364.3 million, and $338.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 501,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 333.00 Mn |
| Mar 31, 2026 | 274.90 Mn |
| Dec 31, 2025 | 364.30 Mn |
| Sep 30, 2025 | 338.70 Mn |
| Jun 30, 2025 | 309.50 Mn |
| Mar 31, 2025 | 322.20 Mn |
| Dec 31, 2024 | 301.30 Mn |
| Sep 30, 2024 | 309.10 Mn |
| Jun 30, 2024 | 278.10 Mn |
| Mar 31, 2024 | 306.60 Mn |
| Dec 31, 2023 | 217.10 Mn |
| Sep 30, 2023 | 267.60 Mn |
| Jun 30, 2023 | 259.20 Mn |
| Mar 31, 2023 | 240.90 Mn |
| Dec 31, 2022 | 132.10 Mn |
| Sep 30, 2022 | 239.30 Mn |
| Jun 30, 2022 | 116.00 Mn |
| Mar 31, 2022 | 239.90 Mn |
| Dec 31, 2021 | 112.20 Mn |
| Sep 30, 2021 | 162.70 Mn |